Session 11: Novel Gamma Delta T Cell Therapy Platforms for Oncology
29th Annual PCF Scientific Retreat: October 29, 2022 | 10:00 AM – 11:45 AM
Moderator: Marco Gottardis, PhD
Janssen Research & Development, LLC
Introduction
Marco Gottardis, PhD
Janssen Research & Development, LLC
Primer on the Biology of γδ T cells and their Use in Cancer Cell Therapy
Sandy Hayes, PhD
Janssen
Novel γδ T Cell Therapy Platform
Lawrence Lamb, Jr., PhD
IN8bio
Bispecific γδ T Cell Engagers for the Treatment of Prostate Cancer
Paul Parren, PhD
LAVA Therapeutics
Using iPSC-derived γδ CAR-T cells to Overcome the TME barrier in Solid Tumors
Hy Levitsky, MD
CENTURY TX